His most recent role at Biogen was as Senior Vice President, U.S. Commercial, where he was the general manager of the MS, hemophilia, and SMA franchises. Derek DiRocco is a Partner at RA Capital Management. Jake works on both public and private investments and serves as a Board Director for Xenikos, B.V, Tyra Biosciences, AavantiBio, and DiCE Molecules. Ramin Farzaneh-Far is a Venture Partner at RA Capital where he works closely with RAs Venture Team to evaluate drug discovery platforms and initiate novel therapeutics programs. Habib Dable is a Venture Partner at RA Ventures (RAVen), focusing on advising and supporting newcos, portfolio companies and executives within RAVen. Parents need to know that Peter Pan & Wendy takes on some of the weightier themes of J.M. Peter Kolchinsky 285 Followers Scientist turned biotech investor, always learning, guided by fatherhood, share The Economist's world view, inspired to write by Hamilton's Federalist Papers. Erin Clutter is the Head of Graphics at RA Capital Management. Most recently, he was Chief Technology Officer at Vor Bio where he built the technical operations team responsible for process development, analytical development, supply chain and manufacturing support of a CRISPR gene-edited HSPC product and oversaw the companys CAR-T efforts. Alyssa previously worked as a Senior Scientist at Eagle Pharmaceuticals. His laboratory at the Broad focused on advanced high throughput biotechnology tools including DNA synthesis, single cell analysis, synthetic biology derived biomolecule libraries, and microbiome profiling. Prior to his time at Merck, Michael held discovery leadership roles at Immunext and Tolerx. Brian Lewandowski is an Analyst on the Investment Team at RA Capital Management. Tom Thomas is an Associate with the TechAtlas division of RA Capital Management. in Immunology from National Taiwan University College of Medicine, and a PhD in Biomedical Science from The Ohio State University. 239 Kelton St, Allston, MA . Jaimie Kirkpatrick is a Research Assistant at RA Capital Management. Kyle also recently retired as a Colonel in the US Army Reserve after 24 years of service. Mark began his professional career as a life sciences attorney with the law firm of Hale and Dorr (now WilmerHale). Cosmas received his BS in Physics from Massachusetts Institute of Technology and his MD from Rutgers-New Jersey Medical School. Her primary responsibilities are to provide strategic administrative support and to assist the co founder in various external and internal projects She previously held Senior Executive Assistant roles at Genuity Science and Charles River Laboratories, and served as Director of Operations at Gloucester Graphics, Inc. Amber has a dual BA concentration in International Business & Modern Languages from Northeastern University and studied abroad at American University of Paris. Adam Rosenberg is an Advisor for RA Capital Management. Laura previously worked at WinterWyman where she served as a Senior Associate. Kate previously served as Health Law Assistant at Mintz. Prior to RA, Michael was a Special Projects Manager at Baupost, LLC where he led a large project to transition the business model to utilize third party fund administration, including management of the implementation. He previously worked as a Software Engineer for several companies, including Autodesk, the Advisory Board Company, and Maveric Systems. Michael received his undergraduate degree at Georgetown University and his medical degree at the Medical University of South Carolina. Kathryn has a BS in Exercise and Health Science from the University of Massachusetts Boston. Angela's primary responsibilities at RAVen are to lead development and oversee implementation of best practices in clinical strategies in RA's newcos and portfolio companies. His doctoral research focused on breast cancer metastasis. Neil has spent five years at RA Ventures where he was most recently Vice President, CMC and worked across new company formation and in support of portfolio companies. April 28, 2023 9:39am. Patrick received his PhD in Natural Sciences, specifically Biochemistry and Molecular Biology, from the Leopold-Franzens University, Innsbruck, Austria. Sadik holds a bachelor of science degree in Cell and Molecular Biology from Tulane University, and earned his PhD in Microbiology and Immunology from Louisiana State University. Josh is currently a faculty member at Harvard Medical School and continues to practice medicine as an attending physician in the Department of Emergency Medicine at Massachusetts General Hospital. Before her time at New Care, she was a Student Researcher at Boston Childrens Hospital Labs of Cognitive Neuroscience. Nate has a BS in Biological Sciences from University of Vermont. In this role, he works closely with the RA Venture team to evaluate and incubate early-stage therapeutic programs. Priscilla has a B.S. in Biomedical Anthropology from the University of Pennsylvania. Kriti holds a B.S. Mario has more than two decades of experience in vaccinology, virology and immunology in large pharma, government, academy, and biotech settings. Peter's age is in line with some of the older Vanderpump Rules cast members, like Jax, Tom Sandoval, and Tom Schwartz. Kates primary responsibilities are to drive internal and external strategic and diligence initiatives and oversee the workflow and professional development of TechAtlas Associates. Peterconducts due diligence on biotechnology companies at RA Capital, and advises RA's portfolio companies on many aspects of program and pipeline strategy. Prior to Flagship, Emily held roles as Associate Director, Head of Global Talent Acquisition and Associate Director, Recruiting Operations & Analytics at bluebird bio. James was a post-doctoral fellow at Massachusetts Institute of Technology and University of California, Berkeley. Jess'sprimary responsibility is to direct a concerted effort to analyze, design, and shape internal and external narratives. Daniel has a BS in Mechanical Engineering from Lehigh University and a MS in Energy Policy & Climate from Johns Hopkins University. Gunes holds a BSc in Biological Sciences and Bioengineering from Sabanci University, a MSc in Molecular and Cellular Biology and a PhD in Biochemistry from the University of Heidelberg. Lorena has dual degrees from Beijing Foreign Studies University: a Bachelor of Business Administration in Accounting and a Bachelor of Arts in English Literature. Adisons primary responsibilities are to coordinate calendars, events, and company meetings for the Investment Team. Milind has co-authored more than 80 scientific articles, is co-inventor on 30 patents, and is a frequent speaker at international scientific conferences. Prior to Point32Health, Michael served as CMO of Harvard Pilgrim Health Care, the Corporate Medical Director at Humana and also served as Vice President of Network and Consumer Solutions for UnitedHealth Groups subsidiary Ingenix (now part of Optum). Since 2002, he has been working in start-up pharma companies, including co-founding Thesan Pharmaceuticals and NeoKera, where he assumed responsibilities for all development activities, including regulatory affairs. Brackett Hardy is a Junior Associate with the TechAtlas division of RA Capital Management. Sams primary responsibility is to help guide internal software development to support competitive landscapes of drugs and medical devices across a range of disease indications and capabilities. Sadik Kassim is a scientist and executive with extensive experience in the biotechnology industry with a specific focus on cell and gene therapy bioprocessing and translational research. Tom holds a BS in Health Sciences with a minor in Journalism from Northeastern University. Prior to RAVen, Cosmas was an Entrepreneur in Residence at Third Rock Ventures and was part of the teams that built Asher Bio (cell targeted biologics for oncology/autoimmune diseases) and Septerna (GPCR focused drug discovery) as well as other NewCOs in development. Alyssas primary responsibilities are to drive internal and external strategic and diligence initiatives and oversee the workflow and professional development of TechAtlas Associates. Prior to joining RAVen, Kat was a Partner at van den Boom & Associates where she provided accounting and finance services including new company formation through IPO and public company accounting support, SOX compliance implementation, and financial modeling to several public and private life science companies. Prior to joining RA, Michael was Associate Vice President at Merck Research Labs. Craig is admitted to practice law in the Commonwealth of Massachusetts. Scott brings to RAVen 20 years of experience working with clients and portfolio companies to complete transactions including multiple IPOs and acquisitions of portfolio companies. Emory has a BS from Vassar College and an MD from the Harvard-MIT Health, Science, Technology Program at Harvard Medical School. Emilies primary responsibility at RA Capital is to manage current and potential investor relationships. Prior to KPMG, Ryan worked at Morris and Morris, P.C. Cosmass academic research has been published in journals such as Cell, Science, and Nature. Max DeNies is a Senior Associate with the TechAtlas division of RA Capital Management. Emily Greenis a Visual Identity Designer at RA Capital Management. He conducted his postdoctoral research at Brigham and Womens Hospital/Harvard Medical School, where he researched the role of the Wnt signaling pathway in mouse models of kidney disease, and was part of a team that discovered a stem cell subtype responsible for solid organ fibrosis. Prior to joining RA, Brigid was the Head of Venture Investments for BHP Ventures, the internal venture capital unit within the worlds largest mining company, where her investment mandate was to help the decarbonization of BHPs operations and to improve the sustainability of resource extraction. Kaleens primary responsibility is to oversee the initiation, planning, and execution of various projects within the TechAtlas Division. Not so long ago, his mother and father were not rich. At Prevail, Emily led business functions including business development, strategy, commercialization, public relations, patient advocacy, and intellectual property, and co-led financings generating $250 million in proceeds, including the companys IPO in 2019. Joey ONeill is an Investor Services Associate at RA Capital Management. Brendan holds a MS in Accounting with a concentration in Taxation from Merrimack College and a BA in Economics from University of Massachusetts Amherst. Habib has earned his Director Professionalism Certificate from the National Association of Corporate Directors. Brett Scheller is a Compliance Officer at RA Capital Management. and Ultragenyx Pharmaceuticals. Jake Simson is a Partner at RA Capital Management. Brendans primary responsibility is managing all aspects of the tax function. He works closely with RA's Investment Team on novel drug discovery platforms with emphasis on computational chemistry and machine learning. Previously, Neil was Director, Business Development and Project Management at CiVentiChem (acquired by Sterling Pharma Solutions). Mario held a Project Director position at BARDA working on Universal Flu Vaccine and leading the technical selection and completion of multiyear/multi million vaccine development programs. Sonias primary responsibility at RA Capital is to create competitive landscapes of drugs and medical devices for disease indications and capabilities. Matt has a BA in Biology with minors in Mathematics and Physics from Ithaca College, a Master of Science in Bioinformatics from Northeastern University, and a PhD in Molecular Biology with a specialization in quantitative biology from Brandeis University. In addition to The Great American Drug Deal, he is the author of The Entrepreneurs Guide to a Biotech Startup. Adam was most recently President, CEO and member of the Board of Directors of Rodin Therapeutics until its acquisition by Alkermes in 2019. Peter Kolchinsky, RA Capital's founder and managing partner. Peter Kolchinsky An excellent example of when knowledge meets power, former Harvard virology doctoral recipient Kolchinsky has put his brainpower to work behind RA Capital Management, with astonishing results in biotech specialization. Within the last 20 years alone, PJ Hogan had a go with 2003's Peter Pan (a major, almost $100m-losing flop), Joe Wright tried again in 2015 with the more radical Pan (another massive failure . Michael held leadership positions at Citigroup Hedge Fund Services in both Fund Accounting and Product Management before joining Centerbridge. Jaimie's primary responsibility is to conduct research and analysis for competitive landscapes of drugs and medical devices across a range of disease indications and capabilities. Prior to MassTech, Natalie held varying Administrative roles at Northeastern University, Framingham Public Schools, and Bright Horizons Family Solutions. Michael earned a DVM at the University of Pretoria and a PhD in Immunology at the University of Pennsylvania. Prior to RA Capital, Nate worked as an Investment Analyst at Wolfram Ventures. Ally coached Women's Lacrosse at Muhlenberg College in PA. This helps us to provide you with a good experience when you browse our website, and also allows us to improve our site. Sarah joined our team from MPM Capital where she served as the COO & General Counsel. Prior to moving to BMS, he spent five years at Hoffmann La-Roche as a research scientist. FORBES estimates that Roivant is worth $3.5 billion, making its Millennial founder's 20% or so stake worth some $700 million. Prior to Relay, she worked as an Executive Assistant at Bullhorn, Inc. Phi holds an Associate in Science Business Administration from Middlesex Community College. MarketScreener: Created by Investors for Investors! Habib received his BBA in Marketing & Finance and his MBA in International Business from University of New Brunswick. Shan Shan Wang is an Associate Director within the TechAtlas division at RA Capital Management. Kats primary responsibility is supporting newcos, portfolio companies and executives within RAVen, focusing on strategic finance.

Calories In 8 Oz Baked Potato No Skin, Presbyterian Charge And Benediction, Nancy Ellen Gerstein,, Articles P